# Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity

> **NCT00957866** · PHASE4 · COMPLETED · sponsor: **University of Manitoba** · enrollment: 160 (estimated)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pegylated Interferons (Peg-IFN) and Ribavirin

## Key facts

- **NCT ID:** NCT00957866
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-10
- **Final completion:** 2012-11
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2014-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957866, "Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00957866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*